(Q35120725)

6 August 2017

Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumonia (English)

1 reference

sulfamethoxazole/trimethoprim

6 August 2017

1 reference

1 reference

pneumocystis carinii

1 reference

Joos B

1

1 reference

6 August 2017

Blaser J

2

1 reference

6 August 2017

Opravil M

3

1 reference

6 August 2017

Chave JP

4

1 reference

6 August 2017

Lüthy R

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

1 reference

6 August 2017

39

1 reference

6 August 2017

12

1 reference

6 August 2017

2661-2666

1 reference

Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Serum trimethoprim and sulphamethoxazole levels in AIDS.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Adverse reactions to co-trimoxazole in HIV infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163008

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

27 September 2018

1 reference

12 December 2020

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

1 reference

12 December 2020

Sulphamethoxazole acetylation in fast and slow acetylators

1 reference

12 December 2020

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions

1 reference

12 December 2020

Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy

1 reference

12 December 2020

Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients

1 reference

12 December 2020

Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.39.12.2661

1 reference

6 August 2017

1 reference

6 August 2017

1 reference